Going Long Russia: Part 1

Jim Rogers is one of my favorite investors to listen to. Truth be told, every Sunday I search YouTube to see if there are any newly released videos of Jim Rogers' views on economies and markets. Rogers is one of the greatest investors of all time, joining forces with George Soros to create the Quantum … Continue reading Going Long Russia: Part 1

Juniper Pharmaceuticals Distress Play

Pharmaceutical companies. When I think of biopharma, the first word that pops into my head is, "stressful". I'm right, to an extent. Pharmaceutical companies, especially those in the small cap / micro cap space live and die by drug approvals and pipeline passes. Failure to pass a drug test or failure to bring a product … Continue reading Juniper Pharmaceuticals Distress Play

GameStop: More Than Meets The Eye

In my previous article, which you can find here, I outlined how one can fall into value traps when searching for potential value investments. There's been a few sectors over the course of the past few months where value traps are hidden, namely oil & gas, oil refinery, and retail (global and domestic), to name … Continue reading GameStop: More Than Meets The Eye

Intel Corp. (INTC) Analysis

Financial Tidbits Operating income declining since 2014. Increased revenues each year going back to 2014 Research and Development costs have increased each year since 2010. Net Cash from Operations steady at around $20,000(million) Net Cash used for investing increased dramatically in 2016, from $8,183 in 2015, to $25,817 in 2016. Net Cash used in financing … Continue reading Intel Corp. (INTC) Analysis